AnkelH., WestraD.F., Welling-WesterS., LebonP.1998. Induction of interferon-α by glycoprotein D of herpes simplex virus: A possible role of chemokine receptors. Virology, 251:317–326.
2.
AravalliR.N., HuS., RowenT.N., PalmquistJ.M., LokensgardJ.R.2005. Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J. Immunol., 175:4189–4193.
CroenK.D., OstroveJ.M., DragovicL.J., SmialekJ.E., StraussS.E.1987. Latent herpes simplex virus in human trigeminal ganglia. N. Engl. J. Med., 317:1427–1432.
5.
Da CostaX.J., BrockmanM.A., AlicotE., MaM., FischerM.B., ZhouX., KnipeD.M., CarrollM.C.1999. Humoral response to herpes simplex virus is complement-dependent. Proc. Natl. Acad. Sci. U.S.A., 96:12708–12712.
6.
DeLucaN.A., McCarthyA.M., SchafferP.A.1985. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J. Virol., 56:558–570.
7.
DeLucaN.A., SchafferP.A.1987. Activities of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides. Nucleic Acids Res., 15:4491–4511.
8.
DolanA., JamiesonF.E., CunninghamC., BarnettB.C., McGeochD.J.1998. The genome sequence of herpes simplex virus type 2. J. Virol., 72:2010–2021.
9.
DowlerK.W., VeltriR.W.1984. In vitro neutralization of HSV-2: Inhibition by binding of normal IgG and purified Fc to virion Fc receptor (FcR)J. Med. Virol., 13:251–259.
10.
FraefelC., SongS., LimF., LangP., YuL., WangY., WildP., GellerA.I.1996. Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J. Virol., 70:7190–7197.
11.
FramptonA.R.Jr., GoinsW.F., NakanoK., BurtonE.A., GloriosoJ.C.2005. HSV trafficking and development of gene therapy vectors with applications in the nervous system. Gene Ther., 12:891–901.
12.
GellerA.I., KeyomarsiK., BryanJ., PardeeA.B.1990. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: Potential applications to human gene therapy and neuronal physiology. Proc. Natl. Acad. Sci. U.S.A., 87:8950–8954.
13.
GeraghtyR.J., KrummenacherC., CohenG.H., EisenbergR.J., SpearP.G.1998. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science, 280:1618–1620.
14.
GruenheidS., GatzkeL., MeadowsH., TufaroF.1993. Herpes simplex virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans. J. Virol., 67:93–100.
15.
GrunewaldK., DesaiP., WinklerD.C., HeymannJ.B., BelnapD.M., BaumeisterW., StevenA.C.2003. Three-dimensional structure of herpes simplex virus from cryo-electron tomography. Science, 302:1396–1398.
16.
HeroldB.C., WuDunnD., SoltysN., SpearP.G.1991. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol., 65:1090–1098.
17.
HockC., KonietzkoU., StrefferJ.R., TracyJ., SignorellA., Müller-TillmannsB., LemkeU., HenkeK., MoritzE., GarciaE., WollmerM.A., UmbrichtD., de QuervainD.J., HofmannM., MaddalenaA., PapassotiropoulosA., NitschR.M.2003. Antibodies against β-amyloid slow cognitive decline in Alzheimer's disease. Neuron, 38:547–554.
18.
HomaF.L., BrownJ.C.1997. Capsid assembly and DNA packaging in herpes simplex virus. Rev. Med. Virol., 7:107–122.
19.
JohnsonP.A., MiyanoharaA., LevineF., CahillT., FriedmannT.1992a. Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J. Virol., 66:2952–2965.
20.
JohnsonP.A., MiyanoharaA., LevineF., CahillT., FriedmannT.1992b. Cytotoxicity of a replication-defective mutant of herpes simplex virus type I. J. Virol., 66:2952–2965.
21.
JohnsonR.M., LanckiD.W., SperlingA.I., DickR.F., SpearP.G., FitchF.W., BluestoneJ.A.1992. A murine CD4–, CD8– T cell receptor-γδ T lymphocyte clone specific for herpes simplex virus glycoprotein I. J. Immunol., 148:983–988.
KrummenacherC., RuxA.H., WhitbeckJ.C., Ponce-de-LeonM., LouH., BaribaudI., HouW., ZouC., GeraghtyR.J., SpearP.G., EisenbergR.J., CohenG.H.1999. The first immunoglobulin-like domain of HveC is sufficient to bind herpes simplex virus gD with full affinity, while the third domain is involved in oligomerization of HveC. J. Virol., 73:8127–8137.
26.
Kurt-JonesE.A., ChanM., ZhouS., WangJ., ReedG., BronsonR., ArnoldM.M., KnipeD.M., FinbergR.W.2004. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. U.S.A., 101:1315–1320.
27.
KwonB.S., TanK.B., NiJ., OhK.O., LeeZ.H., KimK.K., KimY.J., WangS., GentzR., YuG.L., HarropJ., LynS.D., SilvermanC., PorterT.G., TrunehA., YoungP.R.1997. A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J. Biol. Chem., 272:14272–14276.
LesneS., KohM.T., KotilinekL., KayedR., GlabeC.G., YangA., GallagherM., AsheK.H.2006. A specific amyloid-β protein assembly in the brain impairs memory. Nature, 440:352–357.
30.
LubinskiJ.M., WangL., SoulikaA.M., BurgerR., WetselR.A., ColtenH., CohenG.H., EisenbergR.J., LambrisJ.D., FriedmanH.M.1998. Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo. J. Virol., 72:8257–8263.
31.
LundJ., SatoA., AkiraS., MedzhitovR., IwasakiA.2003. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med., 198:513–520.
32.
MarconiP., KriskyD., OliginoT., PolianiP.L., RamakrishnanR., GoinsW.F., FinkD.J., GloriosoJ.C.1996. Replication-defective herpes simplex virus vectors for gene transfer in vivo. Proc. Natl. Acad. Sci. U.S.A., 93:11319–11320.
33.
McGeochD.J., DalrympleM.A., DavisonA.J., DolanA., FrameM.C., McNabD., PerryL.J., ScottJ.E., TaylorP.1988. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol., 69:1531–1574.
34.
MeignierB., LongneckerR., RoizmanB.1988. In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: Construction and evaluation in rodents. J. Infect. Dis., 158:602–614.
35.
MelchjorsenJ., SirenJ., JulkunenI., PaludanS.R., MatikainenS.2006. Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-κB and IRF-3. J. Gen. Virol., 87:1099–1108.
36.
MellerickD.M., FraserN.W.1987. Physical state of the latent herpes simplex virus genome in a mouse model system: Evidence suggesting an episomal state. Virology, 158:265–275.
37.
MettenleiterT.C.2003. Pathogenesis of neurotropic herpesviruses: Role of viral glycoproteins in neuroinvasion and transneuronal spread. Virus Res., 92:197–206.
38.
MontgomeryR.I., WarnerM.S., LumB.J., SpearP.G.1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell, 87:427–436.
39.
NewcombW.W., HomaF.L., ThomsenD.R., TrusB.L., ChengN., StevenA., BooyF., BrownJ.C.1999. Assembly of the herpes simplex virus procapsid from purified components and identification of small complexes containing the major capsid and scaffolding proteins. J. Virol., 73:4239–4250.
40.
NicolaA.V., Ponce de LeonM., XuR., HouW., WhitbeckJ.C., KrummenacherC., MontgomeryR.I., SpearP.G., EisenbergR.J., CohenG.H.1998. Monoclonal antibodies to distinct sites on herpes simplex (HSV) glycoprotein D block HSV binding to HVEM. J. Virol., 72:3595–3601.
41.
NicollJ.A., WilkinsonD., HolmesC., SteartP., MarkhamH., WellerR.O.2003. Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: A case report. Nat. Med., 9:448–452.
42.
OjalaP.M., SodeikB., EbersoldM.W., KutayU., HeleniusA.2000. Herpes simplex virus type 1 entry into host cells: Reconstitution of capsid binding and uncoating at the nuclear pore complex in vitro. Mol. Cell. Biol., 20:4922–4931.
43.
OlschowkaJ.A., BowersW.J., HurleyS.D., MastrangeloM.A., FederoffH.J.2003. Helper-free HSV-1 amplicons elicit a markedly less robust innate immune response in the CNS. Mol. Ther., 7:218–227.
44.
PostL.E., RoizmanB.1981. A generalized technique for deletion of specific genes in large genomes: α gene 22 of herpes simplex virus 1 is not essential for growth. Cell, 25:227–232.
45.
PostL.E., MackemS., RoizmanB.1981. Regulation of α genes of herpes simplex virus: Expression of chimeric genes produced by fusion of thymidine kinase with α gene promoters. Cell, 24:555–565.
46.
RoizmanB., JenkinsF.J.1985. Genetic engineering of novel genomes of large DNA viruses. Science, 229:1208–1214.
47.
SacksW.R., GreeneC.C., AschmanD.P., SchafferP.A.1985. Herpes simplex virus type 1 ICP27 is an essential regulatory protein. J. Virol., 55:796–805.
48.
SaekiY., IchikawaT., SaekiA., ChioccaE.A., ToblerK., AckermannM., BreakefieldX.O., FraefelC.1998. Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: Rescue of replication-competent virus progeny and packaging of amplicon vectors. Hum. Gene Ther., 9:2787–2794.
49.
SaekiY., FraefelC., IchikawaT., BreakefieldX.O., ChioccaE.A.2001. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Mol. Ther., 3:591–601.
50.
SamaniegoL.A., NeiderhiserL., DeLucaN.A.1998. Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J. Virol., 72:3307–3320.
51.
ShiehM.T., WuDunnD., MontgomeryR.I., EskoJ.D., SpearP.G.1992. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol., 116:1273–1281.
52.
ShihM.F., ArsenakisM., TiollaisP., RoizmanB.1984. Expression of hepatitis B virus S gene by herpes simplex virus type 1 vectors carrying α- and β-regulated gene chimeras. Proc. Natl. Acad. Sci. U.S.A., 81:5867–5870.
53.
SodeikB., EbersoldM.W., HeleniusA.1997. Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J. Cell Biol., 136:1007–1021.
54.
SpaeteR.R., FrenkelN.1982. The herpes simplex virus amplicon: A new eucaryotic defective-virus cloning-amplifying vector. Cell, 30:295–304.
55.
SpearP.1993. Entry of alphaherpesviruses into cells. Semin. Virol., 4:167–180.
56.
SpearP.G.2004. Herpes simplex virus: Receptors and ligands for cell entry. Cell Microbiol., 6:401–410.
57.
StavropoulosT.A., StrathdeeC.A.1998. An enhanced packaging system for helper-dependent herpes simplex virus vectors. J. Virol., 72:7137–7143.
58.
StevenA.C., SpearP.G.1997ChiuW.B., GarceaR.Herpesvirus capsid assembly and envelopment. Structural Biology of Viruses. Oxford University Press: New York, 312–351.
59.
StevensJ.G., WagnerE.K., Devi-RaoG.B., CookM.L., FeldmanL.T.1987. RNA complementary to a herpesvirus a gene mRNA is predominant in latently infected neurons. Science, 235:1056–1059.
60.
Tal-SingerR., PengC., Ponce De LeonM., AbramsW.R., BanfieldB.W., TufaroF., CohenG.H., EisenbergR.J.1995. Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J. Virol., 69:4471–4483.
61.
TomazinR., HillA.B., JugovicP., YorkI., van EndertP., PloeghH.L., AndrewsD.W., JohnsonD.C.1996. Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J., 15:3256–3266.
62.
WadsworthS., JacobR.J., RoizmanB.1975. Anatomy of herpes simplex virus DNA. II. Size, composition, and arrangement of inverted terminal repetitions. J. Virol., 15:1487–1497.
63.
WarnerM.S., GeraghtyR.J., MartinezW.M., MontgomeryR.I., WhitbeckJ.C., XuR., EisenbergR.J., CohenG.H., SpearP.G.1998. A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Virology, 246:179–189.
64.
WoodM.J.A., ByrnesA.P., PfaffD.W., RabkinS.D., CharltonH.M.1994. Inflammatory effects of gene transfer into the CNS with defective HSV vectors. Gene Ther., 1:283–291.
65.
WuDunnD., SpearP.G.1989. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol., 63:52–58.
